These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6644694)

  • 21. A modified model of graft-versus-host-induced systemic sclerosis (scleroderma) exhibits all major aspects of the human disease.
    Ruzek MC; Jha S; Ledbetter S; Richards SM; Garman RD
    Arthritis Rheum; 2004 Apr; 50(4):1319-31. PubMed ID: 15077316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma.
    McCormick LL; Zhang Y; Tootell E; Gilliam AC
    J Immunol; 1999 Nov; 163(10):5693-9. PubMed ID: 10553100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Dermatologic aspects of collagen disease (author's transl)].
    Quiñones PA
    An Esp Pediatr; 1981 Jul; 15(1):63-8. PubMed ID: 7316292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between the concentration of serum anti-topoisomerase I autoantibodies and histological and biochemical alterations in the skin of tight skin mice.
    Hatakeyama A; Kasturi KN; Wolf I; Phelps RG; Bona CA
    Cell Immunol; 1996 Jan; 167(1):135-40. PubMed ID: 8548837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Animal model of sclerotic skin. V: Increased expression of alpha-smooth muscle actin in fibroblastic cells in bleomycin-induced scleroderma.
    Yamamoto T; Nishioka K
    Clin Immunol; 2002 Jan; 102(1):77-83. PubMed ID: 11781070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A role for T helper 2 cells in mediating skin fibrosis in tight-skin mice.
    Ong CJ; Ip S; Teh SJ; Wong C; Jirik FR; Grusby MJ; Teh HS
    Cell Immunol; 1999 Aug; 196(1):60-8. PubMed ID: 10486156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Animal models of scleroderma.
    Lakos G; Takagawa S; Varga J
    Methods Mol Med; 2004; 102():377-93. PubMed ID: 15286396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of beta1 integrin in mouse fibroblasts results in resistance to skin scleroderma in a mouse model.
    Liu S; Kapoor M; Denton CP; Abraham DJ; Leask A
    Arthritis Rheum; 2009 Sep; 60(9):2817-21. PubMed ID: 19714619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disruption of tumor necrosis factor receptor p55 impairs collagen turnover in experimentally induced sclerodermic skin fibroblasts.
    Murota H; Hamasaki Y; Nakashima T; Yamamoto K; Katayama I; Matsuyama T
    Arthritis Rheum; 2003 Apr; 48(4):1117-25. PubMed ID: 12687556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Thoracic lesions in collagen diseases].
    Mikami R
    Nihon Kyobu Shikkan Gakkai Zasshi; 1972 Feb; 10(2):65-6. PubMed ID: 4676704
    [No Abstract]   [Full Text] [Related]  

  • 31. The bleomycin-induced scleroderma model: what have we learned for scleroderma pathogenesis?
    Yamamoto T
    Arch Dermatol Res; 2006 Feb; 297(8):333-44. PubMed ID: 16402183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of the tight-skin phenotype in immune-deficient mice.
    Dodig TD; Mack KT; Cassarino DF; Clark SH
    Arthritis Rheum; 2001 Mar; 44(3):723-7. PubMed ID: 11263788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Reactive pathological changes of the parenchyma in collagenosis induced by beta-aminopropionitrile].
    Ifrim M; Papilian VV
    Verh Anat Ges; 1971; 66():329-33. PubMed ID: 4267391
    [No Abstract]   [Full Text] [Related]  

  • 34. [Intestinal lesions in collagen diseases].
    Niwa H
    Nihon Rinsho; 1978 May; Suppl():2102-3. PubMed ID: 691651
    [No Abstract]   [Full Text] [Related]  

  • 35. Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta.
    Bhattacharyya S; Ghosh AK; Pannu J; Mori Y; Takagawa S; Chen G; Trojanowska M; Gilliam AC; Varga J
    Arthritis Rheum; 2005 Apr; 52(4):1248-58. PubMed ID: 15818659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mast cells and their degranulation in the Tsk mouse model of scleroderma.
    Walker M; Harley R; Maize J; DeLustro F; LeRoy EC
    Proc Soc Exp Biol Med; 1985 Nov; 180(2):323-8. PubMed ID: 4048170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transforming growth factor-beta 1 and collagen gene expression during postnatal skin development and fibrosis in the tight-skin mouse.
    Pablos JL; Everett ET; Harley R; LeRoy EC; Norris JS
    Lab Invest; 1995 Jun; 72(6):670-8. PubMed ID: 7783425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Scleroderma-like remodeling induced by type V collagen.
    Bezerra MC; Teodoro WR; de Oliveira CC; Velosa AP; Ogido LT; Gauditano G; Parra ER; Capelozzi VL; Yoshinari NH
    Arch Dermatol Res; 2006 Jul; 298(2):51-7. PubMed ID: 16710740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of peroxisome proliferator-activated receptor gamma in mouse fibroblasts results in increased susceptibility to bleomycin-induced skin fibrosis.
    Kapoor M; McCann M; Liu S; Huh K; Denton CP; Abraham DJ; Leask A
    Arthritis Rheum; 2009 Sep; 60(9):2822-9. PubMed ID: 19714649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of skin sclerosis by 15deoxy delta12,14-prostaglandin J2 and retrovirally transfected prostaglandin D synthase in a mouse model of bleomycin-induced scleroderma.
    Kohno S; Endo H; Hashimoto A; Hayashi I; Murakami Y; Kitasato H; Kojima F; Kawai S; Kondo H
    Biomed Pharmacother; 2006 Jan; 60(1):18-25. PubMed ID: 16337105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.